Bristol-Myers Squibb Company (BMY)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 75.96 |
| Open | 76.50 |
| Bid | 76.02 x 900 |
| Ask | 76.37 x 3000 |
| Day's range | 75.34 - 77.15 |
| 52-week range | 53.22 - 78.47 |
| Volume | |
| Avg. volume | 15,535,258 |
| Market cap | 162.213B |
| Beta (5Y monthly) | 0.48 |
| PE ratio (TTM) | 26.99 |
| EPS (TTM) | 2.82 |
| Earnings date | 27 July 2022 |
| Forward dividend & yield | 2.16 (2.84%) |
| Ex-dividend date | 31 Mar 2022 |
| 1y target est | 79.40 |
- Zacks
Mirati (MRTX) Seeks EU Nod for Adagrasib to Treat Lung Cancer
Mirati (MRTX) seeks a nod for its lung cancer candidate adagrasib in the European Union. A regulatory filing in the United States is currently under the FDA review with decision pending this year-end.
- Business Wire
Bristol Myers Squibb Data at ASCO and EHA 2022 Highlight Progress in Transforming Treatment for Patients with Cancer and Blood Disorders
PRINCETON, N.J., May 19, 2022--Bristol Myers Squibb Data at ASCO and EHA 2022 Highlight Progress in Transforming Treatment for Patients with Cancer and Blood Disorders
- Zacks
Biotech Stock Roundup: BBIO Up on BMY Deal, GILD & CMRX Offer Updates
Regulatory updates and acquisition news from Bristol Myers' (BMY) and BridgeBio Pharma (BBIO) are a few key highlights from the biotech sector during the past week.
© 2022 Yahoo. All rights reserved.
